This test is most useful if any of these apply to you.
A standard blood count can tell you your red cells are small or your hemoglobin is low. It cannot tell you why. This panel reads the actual makeup of the oxygen-carrying protein inside your red cells and exposes inherited differences that a count alone hides.
That difference matters. Some of these traits are silent in you but serious in your children, and others explain a stubborn anemia that iron pills never fix.
Hemoglobin is the protein in red cells that carries oxygen. Most adults make one dominant type, the main adult hemoglobin (hemoglobin A), plus small amounts of two others. This panel sorts those normal types apart and also looks for structurally altered versions that you can inherit.
The value is in the pattern, not any single number. Read together, the fractions answer three linked questions: are your normal hemoglobins in their expected proportions, is an abnormal variant present, and does the mix point toward thalassemia, a structural variant, or both.
In a healthy adult, hemoglobin A makes up the large majority. A minor adult hemoglobin (hemoglobin A2) sits at roughly 2.5 to 3.5 percent, and the hemoglobin babies make before birth (fetal hemoglobin, or hemoglobin F) drops to a trace. A shift in these small fractions is itself a diagnostic clue, which is why the panel measures them precisely rather than just confirming they are present.
Hemoglobin S, C, E, and D are structural variants, each caused by a single building-block swap in the hemoglobin protein. Hemoglobin S carries a valine in place of glutamic acid at the sixth position of the beta chain (numbered by the long-standing hemoglobin convention), the change that makes red cells stiffen and sickle. Hemoglobin C, hemoglobin E, and hemoglobin D Punjab each carry their own distinct single swaps.
Most of these variants are quiet when you carry one copy. They become clinically important in the homozygous state (two copies of the same variant) or the compound state (two different variants together), where they can cause chronic anemia, red cell destruction, and organ damage. Seeing which variant is present, and how much, is what lets the panel separate a harmless carrier from a disease pattern.
Thalassemias reduce how much normal hemoglobin your body makes, rather than changing its structure. The clearest clue to beta-thalassemia trait on this panel is a rise in hemoglobin A2, with a level of 3.5 percent or higher used as the common screening threshold. A rise in fetal hemoglobin is a supporting clue that helps flag specific subtypes and more severe beta-globin disorders.
| Pattern | What It Suggests |
|---|---|
| Mostly hemoglobin A with hemoglobin A2 above 3.5 percent | Beta-thalassemia trait is likely. Confirm iron status, since iron deficiency can shift this number. |
| A hemoglobin S fraction alongside a larger hemoglobin A fraction | Sickle cell trait, a carrier state that is usually symptom-free. |
| Hemoglobin S with little or no hemoglobin A | A sickle cell disease pattern that warrants prompt confirmation and specialist care. |
| Normal-looking fractions but small red cells | Possible alpha-thalassemia or iron deficiency, neither of which reliably shows up on this panel. |
A raised hemoglobin A2 with small red cells points toward beta-thalassemia trait, and the first companion step is checking iron studies, because iron deficiency can pull this number down and, in borderline cases, mask a carrier. A structural variant such as hemoglobin S, C, E, or D is most consequential for reproductive planning, so a partner's result becomes the next question if you are considering children.
Electrophoresis gives a strong presumptive read, not a final genetic verdict. Borderline, unusual, or mismatched results are confirmed with DNA-based testing, which resolves ambiguous variants and defines the exact thalassemia genotype. Your hemoglobin makeup is inherited and stable, so this is not a test you repeat often. One clean, correctly interpreted result usually stands, though it is worth rechecking if it was drawn soon after a transfusion or during significant iron deficiency.
A few conditions distort the whole panel at once. A recent blood transfusion mixes donor hemoglobin with your own, so testing within about three months of a transfusion can produce a false picture. Iron deficiency can lower hemoglobin A2 and, in borderline cases, obscure a beta-thalassemia carrier, and alpha-thalassemia often leaves the fractions looking normal entirely. This is why results are always read alongside your blood count, iron status, and, when needed, molecular testing.
Hemoglobin Electrophoresis is best interpreted alongside these tests.